Nitrogen mustards

Results: 24



#Item
1

PDF Document

Add to Reading List

Source URL: www.mirg.org

Language: English - Date: 2010-10-19 13:01:09
2Ifosfamide Chemotherapy Information: Ifosfamide Medication information leaflet for

Ifosfamide Chemotherapy Information: Ifosfamide Medication information leaflet for

Add to Reading List

Source URL: www.pics.org.au

Language: English - Date: 2011-05-15 21:55:40
3 improvement in survival compared to chlorambucil, it offers patients another choice in first-line treatment for CLL, and has a manageable toxicity profile. pERC deliberated on the potential cost-effectiveness of obinut

improvement in survival compared to chlorambucil, it offers patients another choice in first-line treatment for CLL, and has a manageable toxicity profile. pERC deliberated on the potential cost-effectiveness of obinut

Add to Reading List

Source URL: www.pcodr.ca

Language: English - Date: 2015-01-09 16:20:37
4 considerably higher than the manufacturer’s estimates. pERC agreed that the EGP’s re-analysis estimates were more reliable than those provided by the submitter and concluded that ofatumumab + chlorambucil is not co

considerably higher than the manufacturer’s estimates. pERC agreed that the EGP’s re-analysis estimates were more reliable than those provided by the submitter and concluded that ofatumumab + chlorambucil is not co

Add to Reading List

Source URL: www.pcodr.ca

Language: English - Date: 2014-12-04 16:10:34
5A Canadian Perspective on the Treatment of Unfit Patients with Chronic Lymphocytic Leukemia David MacDonald, MD, FRCP(C);* Silvy Lachance, MD, FRCP(C), CSPQ;† Loree Larratt, MD, FRCP(C)‡ *Dr. David MacDonald, Assista

A Canadian Perspective on the Treatment of Unfit Patients with Chronic Lymphocytic Leukemia David MacDonald, MD, FRCP(C);* Silvy Lachance, MD, FRCP(C), CSPQ;† Loree Larratt, MD, FRCP(C)‡ *Dr. David MacDonald, Assista

Add to Reading List

Source URL: www.newevidence.com

Language: English - Date: 2013-05-06 11:02:45
6Mesna Injection 100 mg per mL IV-IV-IV Regimen After intravenous administration of an 800-mg dose, the half-lives of mesna and dimesna in the blood are 0.36 hours and 1.17 hours, respectively. Approximately 32% and 33%

Mesna Injection 100 mg per mL IV-IV-IV Regimen After intravenous administration of an 800-mg dose, the half-lives of mesna and dimesna in the blood are 0.36 hours and 1.17 hours, respectively. Approximately 32% and 33%

Add to Reading List

Source URL: www.sagentpharma.com

Language: English - Date: 2014-10-01 09:05:22
7HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use Ifosfamide for Injection safely and effectively. See full prescribing information for Ifosfamide for Injection. Ifos

HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use Ifosfamide for Injection safely and effectively. See full prescribing information for Ifosfamide for Injection. Ifos

Add to Reading List

Source URL: www.accessdata.fda.gov

Language: English - Date: 2014-09-02 17:55:37
8Treanda (bendamustine hydrochloride) Full Safety and Drug Utilization Review Provided in Background Materials Pediatric Advisory Committee Meeting, September 23, 2014

Treanda (bendamustine hydrochloride) Full Safety and Drug Utilization Review Provided in Background Materials Pediatric Advisory Committee Meeting, September 23, 2014

Add to Reading List

Source URL: www.fda.gov

Language: English
9Facts About Nitrogen Mustards

Facts About Nitrogen Mustards

Add to Reading List

Source URL: www.gachd.org

Language: English - Date: 2006-02-09 14:26:26
10Nitrogen Mustards Fact Sheet Description Nitrogen mustards are vesicants and alkylating agents. They are colorless to pale yellow, oily liquids that evaporate slowly. HN-1 has a faint, fishy or musty odor. It is sparingl

Nitrogen Mustards Fact Sheet Description Nitrogen mustards are vesicants and alkylating agents. They are colorless to pale yellow, oily liquids that evaporate slowly. HN-1 has a faint, fishy or musty odor. It is sparingl

Add to Reading List

Source URL: www.dhd2.org

Language: English - Date: 2011-10-22 00:50:47